| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | NSC-87877 | GDSC1000 | pan-cancer | AAC | -0.03 | 0.4 |
| mRNA | BRD-K55116708 | CTRPv2 | pan-cancer | AAC | -0.029 | 0.4 |
| mRNA | VNLG/124 | GDSC1000 | pan-cancer | AAC | -0.027 | 0.4 |
| mRNA | momelotinib | CTRPv2 | pan-cancer | AAC | -0.028 | 0.4 |
| mRNA | tivozanib | CTRPv2 | pan-cancer | AAC | -0.029 | 0.4 |
| mRNA | JQ12 | GDSC1000 | pan-cancer | AAC | -0.029 | 0.4 |
| mRNA | JW-7-24-1 | GDSC1000 | pan-cancer | AAC | -0.025 | 0.4 |
| mRNA | PLX4720 | CTRPv2 | pan-cancer | AAC | -0.028 | 0.4 |
| mRNA | BRD-K07442505 | CTRPv2 | pan-cancer | AAC | 0.029 | 0.4 |
| mRNA | AMG-706 | GDSC1000 | pan-cancer | AAC | -0.029 | 0.4 |